Skip to content
← Back to this collection

PUBLICATIONS · 32986498

Venetoclax Plus Rituximab in Relapsed Chronic Lymphocytic Leukemia: 4-Year Results and Evaluation of Impact of Genomic Complexity and Gene Mutations From the MURANO Phase III Study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2020 Dec 1
First author
Kater AP

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Kater AP
      type
      Author
    2. name
      Wu JQ
      type
      Author
    3. name
      Kipps T
      type
      Author
    4. name
      Eichhorst B
      type
      Author
    5. name
      Hillmen P
      type
      Author
    6. name
      D'Rozario J
      type
      Author
    7. name
      Assouline S
      type
      Author
    8. name
      Owen C
      type
      Author
    9. name
      Robak T
      type
      Author
    10. name
      de la Serna J
      type
      Author
    11. name
      Jaeger U
      type
      Author
    12. name
      Cartron G
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Kater AP
      type
      Author
    2. name
      Wu JQ
      type
      Author
    3. name
      Kipps T
      type
      Author
    4. name
      Eichhorst B
      type
      Author
    5. name
      Hillmen P
      type
      Author
    6. name
      D'Rozario J
      type
      Author
    7. name
      Assouline S
      type
      Author
    8. name
      Owen C
      type
      Author
    9. name
      Robak T
      type
      Author
    10. name
      de la Serna J
      type
      Author
    11. name
      Jaeger U
      type
      Author
    12. name
      Cartron G
      type
      Author
    bibliography ids
    1. nci-bib-896c2aa6deb16697ed713b26
    book metadata
    content sha256
    3ed312fa4a38850f23952d0516c5d0c5a1d4ad35cbad309f0e443b0299b1566d
    document type
    citation
    dois
    1. 10.1200/JCO.20.00948
    electronic publication date
    display
    2020 Sep 28
    precision
    day
    year
    2020
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:32986498
    immutable id
    pubmed:32986498@3ed312fa4a38850f23952d0516c5d0c5a1d4ad35cbad309f0e443b0299b1566d
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    34
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    4042-4054
    volume
    38
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      32986498
      provenance
      batch id
      9bca82d1bba2b27adc79
      provider
      NCBI PubMed ESummary
      record sha256
      d7de3a684ae1e426fa09da8340d397894968d45bf3627c06ceaaceb8b9fd7f81
      response sha256
      c8a4853c65a45038af15f5ade3970763bfa121cf5c68bafcc52c3a06860d0211
      retrieved at
      2026-09-09T23:47:56.131551+00:00
      publication date
      display
      2020 Dec 1
      precision
      day
      year
      2020
      publication types
      1. Clinical Trial, Phase III
      2. Journal Article
      3. Randomized Controlled Trial
      4. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/32986498/
      title
      Venetoclax Plus Rituximab in Relapsed Chronic Lymphocytic Leukemia: 4-Year Results and Evaluation of Impact of Genomic Complexity and Gene Mutations From the MURANO Phase III Study.

      Preserved source evidence · Not medical advice